| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 4 |
| 1 | ACETAMINOPHEN | 2 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 3 | ALEMTUZUMAB | 2 |
| 4 | FLUDARABINE PHOSPHATE | 2 |
| 5 | LEVOTHYROXINE SODIUM | 2 |
| 6 | METHOTREXATE | 2 |
| 7 | METHOTREXATE SODIUM | 2 |
| 8 | RUXOLITINIB | 2 |
| 9 | ACYCLOVIR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEBENTAFUSP | 1 | 0.0017 |
| 1 | MOSUNETUZUMAB | 1 | 0.0009 |
| 2 | GLOFITAMAB | 1 | 0.0004 |
| 3 | AMLODIPINE AND ATORVASTATIN | 1 | 0.0002 |
| 4 | ALEMTUZUMAB | 2 | 0.0001 |
| 5 | CLADRIBINE | 1 | 0.0001 |
| 6 | INSULIN GLULISINE | 1 | 0.0001 |
| 7 | BLINATUMOMAB | 1 | 0.0001 |
| 8 | EPOETIN ALFA | 1 | 0.0001 |
| 9 | VELPATASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 3 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |